RS Bio ApS: Financial statements 2022
CVR: 39970899
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
RS Bio ApS (CVR 39970899) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -267,600 and a net result of DKK -390,326,308 compared with DKK 290,102,085 the year before. Equity in the 2022 report amounted to DKK 109,245,627. The solvency ratio was 98.9%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -267,600
- Profit/Loss
- DKK -390,326,308
- Equity
- DKK 109,245,627
- Total Assets
- DKK 110,469,998
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -268 t. | -390.3 mio. | 109.2 mio. | 1 |
| 2021 | - | -289 t. | 290.1 mio. | 499.6 mio. | 0 |
| 2020 | - | -255 t. | -162.6 mio. | 209.5 mio. | 0 |
| 2019 | - | -234 t. | -131.3 mio. | 337.1 mio. | 0 |
Official annual report
Keep an eye on RS Bio ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
RS Bio ApS has published its annual report for 2021. Gross profit came to DKK -289,381, and the net result was DKK 290,102,085.
About RS Bio ApS
RS Bio ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2018. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Renè Sindlev. The company is owned by RS GROUP ApS and RS2 Holdings ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -93,834 and a net result of DKK 18,815,451 compared with DKK 33,373,796 the year before. Equity in the 2025 report amounted to DKK 439,671,207.